• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Continuous Glucose Monitoring Attrition in Youth With Type 1 Diabetes.1型糖尿病青少年持续葡萄糖监测的损耗情况
Sci Diabetes Self Manag Care. 2025 Feb;51(1):64-72. doi: 10.1177/26350106241306058. Epub 2025 Jan 9.
2
Continuous glucose monitoring systems for type 1 diabetes mellitus.1型糖尿病的连续血糖监测系统
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD008101. doi: 10.1002/14651858.CD008101.pub2.
3
Does the OP5 Automated Insulin Delivery System Close the Gap in Glycemic Control Between White and Black Youth with Type 1 Diabetes?OP5自动胰岛素输送系统能否缩小1型糖尿病白人青年和黑人青年在血糖控制方面的差距?
Diabetes Technol Ther. 2025 Jun;27(6):469-478. doi: 10.1089/dia.2024.0612.
4
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.用于管理1型糖尿病患者血糖水平的集成式传感器增强泵治疗系统[美敦力MiniMed® Paradigm™ Veo系统以及Vibe™和G4® PLATINUM连续血糖监测(CGM)系统]:一项系统综述与经济学评估
Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170.
5
Equity of Continuous Glucose Monitoring in Children and Young People With Type 1 Diabetes: A Systematic Review.1型糖尿病儿童和青少年持续葡萄糖监测的公平性:一项系统评价。
Pediatr Diabetes. 2025 Jun 3;2025:8875203. doi: 10.1155/pedi/8875203. eCollection 2025.
6
Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.持续葡萄糖监测对1型糖尿病患者维持血糖控制的有效性:随机对照试验的系统评价和荟萃分析
Diabetologia. 2022 Apr;65(4):604-619. doi: 10.1007/s00125-021-05648-4. Epub 2022 Feb 9.
7
Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.糖尿病胰岛素给药与血糖监测方法:一项比较有效性综述的总结
J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. doi: 10.18553/jmcp.2012.18.s6-A.1.
8
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.孕前患有糖尿病的女性孕期血糖监测技术。
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3.
9
Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.1型糖尿病中持续葡萄糖监测与自我血糖监测的疗效和安全性比较:系统评价与荟萃分析
Pol Arch Med Wewn. 2011 Oct;121(10):333-43.
10
Updating Our Understanding of Device Use in Adolescents: Demographic Factors and Preferences in a Group of Adolescents With Type 1 Diabetes.更新我们对青少年使用设备的理解:一组 1 型糖尿病青少年的人口统计学因素和偏好。
Sci Diabetes Self Manag Care. 2024 Feb;50(1):9-18. doi: 10.1177/26350106231220023. Epub 2024 Jan 19.

引用本文的文献

1
Diabetes Management Through Remote Patient Monitoring: A Mixed-Methods Evaluation of Program Enrollment and Attrition.通过远程患者监测进行糖尿病管理:项目注册与流失的混合方法评估
Healthcare (Basel). 2025 Mar 22;13(7):698. doi: 10.3390/healthcare13070698.

本文引用的文献

1
Improving equity in diabetes technology use: Voices of youth and their parents.提高糖尿病技术使用的公平性:青年及其父母的声音。
Diabet Med. 2024 Nov;41(11):e15382. doi: 10.1111/dme.15382. Epub 2024 Jun 17.
2
ROUTE-T1D: A behavioral intervention to promote optimal continuous glucose monitor use among racially minoritized youth with type 1 diabetes: Design and development.ROUTE-T1D:一种促进1型糖尿病种族少数族裔青少年最佳使用持续葡萄糖监测仪的行为干预措施:设计与开发。
Contemp Clin Trials. 2024 May;140:107493. doi: 10.1016/j.cct.2024.107493. Epub 2024 Mar 7.
3
Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative.48000 余位 1 型糖尿病患者(2016-2022 年)的血糖控制结果和技术使用的纵向趋势:来自 T1D Exchange 质量改进合作研究。
Diabetes Technol Ther. 2023 Nov;25(11):765-773. doi: 10.1089/dia.2023.0320. Epub 2023 Oct 16.
4
Racial Disparities in Technology Use in Children With Type 1 Diabetes: A Qualitative Content Analysis of Parents' Perspectives.种族差异在 1 型糖尿病儿童技术使用中的体现:基于父母观点的定性内容分析。
Sci Diabetes Self Manag Care. 2023 Feb;49(1):55-64. doi: 10.1177/26350106221145323. Epub 2023 Jan 6.
5
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.闭环与连续皮下胰岛素输注治疗的血糖改善比较:一项随机对照试验的结果。
Diabetes Technol Ther. 2023 Jan;25(1):1-12. doi: 10.1089/dia.2022.0421. Epub 2022 Dec 20.
6
Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action.克服1型糖尿病青少年及公共保险人群使用糖尿病技术的障碍:案例与行动呼吁
Case Rep Endocrinol. 2022 Mar 1;2022:9911736. doi: 10.1155/2022/9911736. eCollection 2022.
7
14. Children and Adolescents: Standards of Medical Care in Diabetes-2022.14. 儿童和青少年:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S208-S231. doi: 10.2337/dc22-S014.
8
Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.需要时的帮助:T1D 成人对开始使用连续血糖监测时他们希望获得的支持和培训的看法。
Diabetes Res Clin Pract. 2021 Oct;180:109048. doi: 10.1016/j.diabres.2021.109048. Epub 2021 Sep 14.
9
Inequities in Health Outcomes in Children and Adults With Type 1 Diabetes: Data From the T1D Exchange Quality Improvement Collaborative.1型糖尿病儿童和成人健康结局的不平等:来自T1D交换质量改进协作组的数据。
Clin Diabetes. 2021 Jul;39(3):278-283. doi: 10.2337/cd21-0028.
10
ONBOARD: A Feasibility Study of a Telehealth-Based Continuous Glucose Monitoring Adoption Intervention for Adults with Type 1 Diabetes.随行研究:基于远程医疗的连续血糖监测采用干预措施对 1 型糖尿病成人患者的可行性研究。
Diabetes Technol Ther. 2021 Dec;23(12):818-827. doi: 10.1089/dia.2021.0198.

1型糖尿病青少年持续葡萄糖监测的损耗情况

Continuous Glucose Monitoring Attrition in Youth With Type 1 Diabetes.

作者信息

Meighan Seema, Lipman Terri H, VanGraafeiland Brigit, Marks Brynn E

机构信息

Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Johns Hopkins School of Nursing, Baltimore, Maryland.

出版信息

Sci Diabetes Self Manag Care. 2025 Feb;51(1):64-72. doi: 10.1177/26350106241306058. Epub 2025 Jan 9.

DOI:10.1177/26350106241306058
PMID:39783011
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12013585/
Abstract

PURPOSE

The purpose of the study was to identify the most common reasons for and timing of continuous glucose monitoring (CGM) attrition in youth with type 1 diabetes (T1DM).

METHODS

This single center retrospective chart review included youth with T1DM <22 years seen between November 1, 2021, and October 31, 2022. Data were gathered from CGM cloud-based software and the electronic medical record.

RESULTS

Among 2663 youth, 88.3% (n = 2351) actively used CGM, and 5.9% (n = 311) had CGM attrition. Those who discontinued CGM were older (17.0 vs 14.9 years, = .0001), had a longer T1DM duration (7.4 vs 5.1 years), higher A1C (9% vs 7.4%), and were non-Hispanic Black (NHB; 34.0% vs 11.5%). The odds of CGM attrition were 5.0 and 2.8 times higher in NHB and Latine youth, respectively, compared to non-Hispanic White youth. Median time to CGM discontinuation was 4 months, 21 days after initiation; 57% of youth who discontinued did so in the first 6 months of use. The most common reasons for CGM attrition were problems with device adhesion (18.4%), dislike device on the body (10.8%), insurance problems (9.5%), pain with device use (8.3%), and system mistrust due to inaccurate readings (8.2%). NHB and Latine youth were more likely to discontinue CGM due to insurance problems (3.2% vs 15.1% vs 16.7%).

CONCLUSIONS

To support equitable, uninterrupted CGM use, education at CGM initiation should address practical approaches to improve adhesion and wearability and provide a clear pathway to obtaining supplies. Interventions to support sustained CGM use should occur within the first 6 months of initiation.

摘要

目的

本研究旨在确定1型糖尿病(T1DM)青少年持续葡萄糖监测(CGM)停用的最常见原因及时间。

方法

这项单中心回顾性病历审查纳入了2021年11月1日至2022年10月31日期间就诊的年龄小于22岁的T1DM青少年。数据从基于CGM的云软件和电子病历中收集。

结果

在2663名青少年中,88.3%(n = 2351)积极使用CGM,5.9%(n = 311)出现CGM停用。停用CGM的青少年年龄较大(17.0岁对14.9岁,P = .0001),T1DM病程较长(7.4年对5.1年),糖化血红蛋白(A1C)较高(9%对7.4%),且为非西班牙裔黑人(NHB;34.0%对11.5%)。与非西班牙裔白人青少年相比,NHB和拉丁裔青少年停用CGM的几率分别高出5.0倍和2.8倍。停用CGM的中位时间为开始后4个月零21天;57%的停用青少年在使用的前6个月内停用。CGM停用的最常见原因是设备粘贴问题(18.4%)、不喜欢身上佩戴设备(10.8%)、保险问题(9.5%)、使用设备时疼痛(8.3%)以及因读数不准确导致对系统不信任(8.2%)。NHB和拉丁裔青少年因保险问题更有可能停用CGM(3.2%对15.1%对16.7%)。

结论

为支持公平、不间断地使用CGM,在开始使用CGM时进行的教育应涉及改善粘贴和可穿戴性的实用方法,并提供获取耗材的明确途径。支持持续使用CGM的干预措施应在开始使用的前6个月内进行。